Skip to content
StockResearch
WAT/History

Waters Corporation (WAT) vs peers

Health Care

$452.23

Latest weekly close · Market cap $44.4B

WAT's EV/EBITDA is 51.9x, compared with 26.9x at the middle of 7 peers.

Peer group: Life Sciences Tools & Services. Updated .

WAT and Life Sciences Tools & Services, ranked by EV/EBITDA
StockEV/EBITDAOwn 5-year percentile
WATWaters Corporation51.9×100
CRLCharles River Laboratories48.3×100
TECHBio-Techne32.5×35
MTDMettler Toledo28.9×72
AAgilent Technologies26.9×91
TMOThermo Fisher Scientific26.1×99
DHRDanaher Corporation24.5×61
IQVIQVIA18.1×74
Peer median26.9×
How to read this comparison

Up to eight covered companies in the same industry, largest market value first.

EV/EBITDA divides enterprise value (market value plus debt, minus cash) by EBITDA over the last twelve months. The peer median leaves out WAT and stocks without a reading.

Each percentile compares a stock with its own weekly readings over the last five years, so 20 means its EV/EBITDA is above 20% of its own past readings. It needs at least 26 weeks of history. It is not a rank against the other stocks in this table.

Different growth rates, margins and financial risks can explain different multiples. Stocks without positive EBITDA have no reading.

WAT versus the peer median

+93%

WAT
51.9×
Peer median
26.9×
Own 5-year median
23.3×
WAT EV/EBITDA historyCalculate WAT's implied price

Source: SEC company filings and weekly market prices. Multiples use the last twelve months of financial results. Updated .

How the valuation data is built